Recall Record

Princeton, NJ, United States

Bionpharma Inc. recalls

4 recalls recorded since 2018, most recently on 7 August 2026. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)2
Terminated or completed2
Class I (FDA)1

Ongoing Class III Drugs

Recall started
7 August 2026
Reason
Presence of Foreign Tablets/Capsules
Distribution
US Nationwide.
Initiated
Voluntary: Firm initiated
Recall number
D-0822-2026

Ongoing Class II Drugs

Recall started
26 June 2026
Reason
Presence of Foreign Tablets/Capsules
Distribution
US Nationwide.
Initiated
Voluntary: Firm initiated
Recall number
D-0742-2026

Terminated Class I Drugs

Recall started
17 September 2024
Terminated
16 September 2025
Reason
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
Distribution
Nationwide in the U.S.A.
Initiated
Voluntary: Firm initiated
Recall number
D-0012-2025

Terminated Class II Drugs

Recall started
16 July 2019
Terminated
5 March 2020
Reason
Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-1519-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.